Polymeric drug delivery of enzymatically degradable pendant agents: Peptidyl-linked procainamide model system studies

Amnon Sintov, Robert J. Levy

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

Biodegradable polymeric drug delivery systems have become increasingly important for sustained release indications when a time-limited drug implant is required. A new methacrylic copolymer consisting of enzymatically-cleavable oligopeptidyl procainamide as pendant side chains was synthesized in a series of three reactions. Using high performance liquid chromatography (HPLC) analysis, procainamide release was monitored while incubating polymer specimens in the presence of a model enzyme, α-chymotrypsin, in a physiologic buffer at 37°C. It was found that the new polymeric drug conjugate was insoluble in aqueous solutions and it was relatively stable when not in the presence of the enzyme, releasing not more than 5 mg of drug/g polymer after 30 days incubation under physiologic conditions. However, in the presence of α-chymotrypsin, the procainamide side chains were gradually enzymatically cleaved over 20 days, and the rate of hydrolysis could be controlled by varying the enzymatic incubation conditions. The enzymatic rate dependency of each formulation was dependent upon the comonomer ratio and the degree of crosslinking. These two factors influenced the accessibility of the water-insoluble polymers to enzyme. It is concluded that procainamide release from an enzymatically degradable pendant-peptide link can be achieved in an enzymatically controllable manner.

Original languageEnglish
Pages (from-to)55-62
Number of pages8
JournalInternational Journal of Pharmaceutics
Volume146
Issue number1
DOIs
StatePublished - 1 Jan 1997

Keywords

  • Biodegradable drug delivery systems
  • Cardiac arrhythmia
  • Controlled drug delivery
  • Methacrylic polymers
  • Polymer synthesis
  • Polymeric prodrugs
  • Procainamide

ASJC Scopus subject areas

  • Pharmaceutical Science

Fingerprint

Dive into the research topics of 'Polymeric drug delivery of enzymatically degradable pendant agents: Peptidyl-linked procainamide model system studies'. Together they form a unique fingerprint.

Cite this